pharma-company /Medicinal products /Active ingredients

Rx · PZN 17903120, 17903137, 19875758, 19787830…

RINVOQ 45 mg prolonged-release tablets

German trade nameRINVOQ 45 mg Retardtabletten

Active ingredientUpadacitinibPharmaceutical formProlonged-release tablets

Consistently available

8.7

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Average purchase price (B2B)

~ €1,693

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

RINVOQ 45 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

RINVOQ 45 mg prolonged-release tablets contains the active ingredient Upadacitinib and comes as Prolonged-release tablets. 7 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 8.7 out of 10. The best-available pack was consistently available.


Pack sizes · 7 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
179031209.48.7~ €1,770
179031370.00.0N/A
198757580.00.0~ €1,677
197878300.00.0~ €1,677
199439450.00.0~ €1,677
199096060.00.0~ €1,677
197717050.00.0~ €1,677

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 6 of 7 PZNs.